Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0065007; biological regulation | GO:0035625; epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 2.121E-06 | 5.774E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0032811; negative regulation of epinephrine secretion | 2.121E-06 | 5.774E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0038171; cannabinoid signaling pathway | 2.121E-06 | 5.774E-03 | CNR1, CNR2 |
BP | GO:0032501; multicellular organismal process | GO:0019233; sensory perception of pain | 4.217E-06 | 7.063E-03 | CNR1, CNR2, MAPK1 |
MF | GO:0060089; molecular transducer activity | GO:0004949; cannabinoid receptor activity | 1.061E-06 | 5.774E-03 | CNR1, CNR2 |
MF | GO:0060089; molecular transducer activity | GO:0004938; alpha2-adrenergic receptor activity | 1.061E-06 | 5.774E-03 | ADRA2A, ADRA2C |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa04015 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 6.820E-03 | 3.902E-02 | CNR1; MAPK1 |
hsa04022 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.190E-04 | 4.559E-03 | MAPK1; ADRA2C; ADRA2A |
hsa04080 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 3.596E-07 | 3.704E-05 | CNR2; CNR1; NMUR2; ADRA2C; ADRA2A |
hsa04723 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.612E-03 | 1.612E-02 | CNR1; MAPK1 |
hsa04725 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.943E-03 | 1.612E-02 | ACHE; MAPK1 |
hsa04726 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.978E-03 | 1.612E-02 | ALOX5; MAPK1 |
hsa04912 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.312E-03 | 1.612E-02 | MMP2; MAPK1 |
hsa04915 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.550E-03 | 1.612E-02 | MMP2; MAPK1 |
hsa04919 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 2.192E-03 | 1.612E-02 | RXRA; MAPK1 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.612E-03 | 1.612E-02 | MMP2; MAPK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Postherpetic neuralgia | B02.2, G44.847, G53.0 | CNR1 |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | Lymphatic filariasis | B74 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MMP2 |
C00-D49: Neoplasms | Cutaneous T-cell lymphoma | C84.0, C84.1 | RXRA |
C00-D49: Neoplasms | Renal cell carcinoma | NA | MMP2 |
C00-D49: Neoplasms | Cancer | C00-C96 | MMP2; MAPK1; ACHE |
C00-D49: Neoplasms | Non-small-cell lung cancer | NA | MMP2 |